Market Analysis
Market Report
LDOS closed at $149.23 on May 1, 2026, just 7% above its 52-week low of $139.69 and a brutal 27.5% below its 52-week high of $205.77. Stock decisively in a downtrend on every framework: price below 50-day SMA ($162.18) by 8.0%, below 200-day SMA ($178.34) by 16.3%, and recently formed a death cross (50 SMA crossing below 200 SMA, in motion since early April).
Trend structure. Three-act drawdown: (1) early-April held the $158-$160 zone with brief test of $162; (2) sharp leg-down between April 16 and April 24 from $156 to $144 (-7.4% in 6 sessions); (3) bounce from the $144 oversold zone to $149.23 over the last 4 sessions on rising volume (May 1 = 1.16M, highest single-day in the period).
Momentum signals — early reversal. MACD line at -4.37 vs. signal -4.49, histogram +0.12 — crossed positive on May 1 for the first time. Textbook bullish histogram divergence. RSI at 39.6 has rallied off a 27.5 oversold low set on April 27, the most extreme reading in the dataset.
Volatility regime. Bollinger middle band $152.95, upper $163.36, lower $142.55 — band width compressed 30% from early April, often precedes directional moves.
Earnings setup. LDOS reports Q1 2026 on May 5 BMO. Consensus: Revenue $4.27B (-0.5% YoY), EPS $2.88 (-3% YoY). Zacks Earnings ESP +0.41% with Strong Buy / Buy / Hold rank suggests positive surprise model. A clean print resolves to 50-day SMA at $162 (+8.5%); a miss takes the stock to $139.69 (-6.4%).
Key technical levels:
| Level | Price | Significance |
| Resistance 1 | $162-$163 | 50-day SMA / Bollinger upper |
| Resistance 2 | $178 | 200-day SMA — must reclaim for trend repair |
| Pivot | $149.23 | Spot / 10 EMA confluence |
| Support 1 | $144 | Recent April 27 low |
| Support 2 | $142 | Bollinger lower / 2-sigma |
| Critical | $139.69 | 52-week low |
Verdict. Tactically oversold with early MACD/RSI confirmation, structurally broken on every moving-average framework. Setup is binary into May 5: beat-and-raise resolves to $162-$170 (+8-14%); in-line-or-miss takes to $140-$145 (-3 to -7%).
| Indicator | Reading | Signal |
| Price vs 50 SMA | -8.0% | Strong bearish |
| Price vs 200 SMA | -16.3% | Strong bearish (death cross) |
| MACD vs Signal | +0.12 (histogram) | Early bullish reversal |
| RSI(14) | 39.6 (off 27.5 low) | Recovering from oversold |
| Bollinger position | Below middle, above lower | Mean-reversion buy zone |
| 10 EMA vs Price | $149.24 ≈ $149.23 | Flat — pivot point |
| 52W High proximity | -27.5% | Deep drawdown |
| 52W Low proximity | +6.8% | Just above floor |
Social Sentiment
Social Sentiment Report
LDOS enters May 2026 in a sentiment vacuum unusual for a $19B mid-cap with this newsflow. Bifurcated: headline-level analyst tone is positive (Zacks "expected to beat earnings"), but the stock action says nobody believes it (down 27% from peak even as bookings momentum accelerates).
Bull narrative — strongest threads:
- IFPC Inc. 2 contract blitz. April 2026: $617M U.S. Army award, cumulative $1.2B, 100+ launchers committed for delivery, R&D funded through 2029.
- MDA SHIELD IDIQ position ($151B ceiling). 10-year vehicle for "Golden Dome" homeland missile defense. Plus DMEA ATSP V $24.5B and AF Air Base Air Defense $2.2B 5-year award. Q4 2025 booking package qualitatively the strongest in years.
- Military OneSource win ($456M). Health & Civil segment story for 4.7M+ eligible service members.
- Analogic JV for security screening. Aligns with 2030 growth strategy and Trump administration homeland security priorities.
Bear narrative — strongest threads:
- Stock down 27% from peak says something is wrong. Defense-IT sector ETFs (ITA, XAR) +6% YTD vs LDOS -22% YTD = -28pp divergence.
- Q4 2025 was -4% YoY revenue. EPS $2.53 down from Q3's $2.82 and Q2's $3.01. Sequential decline.
- FY 2026 guide is +1.7% to +4% revenue. Defensive holding pattern. Adj EBITDA margin guide "mid-13%" vs FY 2025 14.1% — explicit 80bps compression.
- $7B of awards "slipped" from Q4 into Q1. Either timing (which works out) or optimistic forecasting.
- Government shutdown drama recurring. 3 shutdowns in 4 years; FY27 budget negotiations ahead.
Insider transactions: Mixed signals from cache. Net neutral.
| Sentiment lane | Read | Direction |
| Recent contract awards | $617M IFPC, $456M Military OneSource, SHIELD IDIQ | Bullish |
| Sell-side pre-print stance | Beat-the-quarter model triggered | Mild bullish |
| Stock price action | -27% from peak, sector outperformed | Bearish |
| Q4 2025 earnings reaction | "Beats EPS, stock dips" | Mixed |
| FY 2026 guide reception | Margin compression, low growth | Bearish |
| Defense budget tape | European rearmament, Golden Dome | Bullish (macro) |
| Government shutdown overhang | 6-week Q4 2025 disruption | Bearish (recurring) |
| Insider activity | No strong signal | Neutral |
News & Macro
News Report
April-May 2026 macro tape dominated by three forces: (1) Trump administration's homeland security and missile defense build-out (Golden Dome), (2) European rearmament creating exportable demand, (3) recurring federal budget process risk producing 3 shutdowns in 4 years.
Trump-era defense priorities — the Golden Dome thesis. MDA's SHIELD IDIQ ($151B 10-year ceiling) is the operational vehicle for integrated homeland missile defense. Leidos won a position in Q4 2025. First task orders should hit Q2-Q3 2026. Even modest 1-2% share capture implies $1.5B+ of incremental annual revenue at steady-state vs current $17.2B base.
European rearmament — the export tailwind. EU defense spending projected at €420B for 2026 (+18% vs 2025). US defense IT primes positioned for 15-20% via FMS channels. IFPC Inc. 2 system Leidos is building is exactly the integrated air-defense platform European NATO members are requisitioning.
Federal budget risk — the recurring tail. 6-week government shutdown in Q4 2025 hit Leidos -4% YoY. Another shutdown event before FY27 budget enacted is non-trivial risk. September 30 FY-end creates predictable disruption windows.
DoD POM cycle. FY27 POM in HASC/SASC markup, NDAA expected Q4 2026. Topline DoD request $895B (+2%), but missile defense / homeland security line items growing +8-10%. Leidos NS&D (44%) + Defense Systems (13%) = 57% in fast-growing categories.
FAA / civilian government. Health & Civil (30% of revenue) covers VA, FAA, NSF, DoE. Administration priorities of FAA modernization, VA modernization, Energy nuclear modernization all flow to Leidos.
Macroeconomic backdrop. Fed funds 3.75-4.00%, dollar mildly weaker. Long-end rates stabilized 4.20-4.50% 10Y, removing 2024-2025 multiple-compression headwind.
Sector tape. ITA +6% YTD vs LDOS -22% YTD = -28pp divergence. Either uniquely broken or uniquely cheap.
| Macro lane | 2026 reading | Net for LDOS |
| Trump homeland security priority | Golden Dome / SHIELD IDIQ | Bullish |
| European rearmament | EU 2026 defense +18% | Bullish (FMS exposure) |
| DoD FY27 POM cycle | $895B request, +8-10% missile defense | Bullish (segment skew) |
| Government shutdown risk | 6-week Q4 2025 hit; September 30 FY-end | Bearish (recurring) |
| FAA/VA/civilian agency | Modernization priorities | Mild bullish |
| FFP contract exposure | Margin risk on cost overruns | Bearish (mix) |
| Federal interest rates | Stabilizing, mild dollar weakness | Mild bullish |
| Sector relative performance | LDOS -22% YTD vs ITA +6% | Bearish (divergence) |
Fundamental Analysis
Fundamentals Report
LDOS is a defense IT services prime deriving 87% of revenue from US government contracts. High-quality, low-multiple, cash-generative compounder running into challenging mid-cycle revenue trough.
Top line — modest growth, segment skew matters.
| Year | Revenue ($B) | YoY Growth |
| 2023 | 15.4 | +7% |
| 2024 | 16.7 | +8.4% |
| 2025 | 17.2 | +3% |
| 2026E | 17.5-17.9 | +1.7% to +4% |
Deceleration from +8% to +3% is real but normalized for 53rd week (FY24) and 6-week shutdown (Q4 2025) underlying organic growth is closer to +5%.
Quarterly revenue trend (FY 2025):
- Q1 2025: $4.245B
- Q2 2025: $4.253B
- Q3 2025: $4.469B
- Q4 2025: $4.207B (govt shutdown hit)
Q1 2026 consensus $4.27B suggests sequential normalization.
Profitability — improving, with one caveat.
- FY 2025 GM: ~18.0%
- FY 2025 OM: ~12.3% (vs ~10.5% FY 2024 — material expansion)
- FY 2025 Adj EBITDA: $2.42B (14.1% margin)
- ROE: 31.0% (buyback-amplified)
FY 2026 guide of "mid-13%" Adj EBITDA margin is ~80bps below FY 2025.
EPS trend:
- FY 2025 sum: $11.13 (matches TTM EPS)
- FY 2026 guide: $12.05-$12.45 (+8% to +12% YoY)
EPS growth +8-12% on revenue +1.7-4% implies aggressive buyback execution + interest expense reduction doing most of the work.
Balance sheet — manageable leverage.
- Cash (Q4 2025): $1.108B
- Total debt: ~$5.0B
- D/E ratio: 107.7 (highest among peers)
- Current ratio: 1.70x
Cash flow — robust and growing.
- FY 2025 OCF: ~$1.75B
- FY 2025 FCF: $1.625B (TTM)
- FY 2025 capex: $125M
- FCF margin: 9.5%
Capital return.
- FY 2025 buybacks: $944M
- FY 2025 dividends: $211M
- Combined: $1.155B (71% of FCF)
Backlog and book-to-bill — defense-IT critical metric.
- FY 2025 backlog: $49.0B (vs $43.6B FY 2024 = +12.4%)
- Funded backlog: $9.7B (+15% YoY)
- Q4 2025 net bookings: $5.6B (book-to-bill 1.3x)
- Q3 2025 book-to-bill: 1.3x
- FY 2025 book-to-bill: 1.0x
- Pending awards: $20B
- Revenue/Backlog coverage: 2.85x
Customer concentration (10-K Item 1A):
- US Government: 87% of FY 2025 revenue
- International: ~8%
- Commercial: ~5%
Segment mix (FY 2025):
| Segment | % of Revenue |
| National Security & Digital | 44% |
| Health & Civil | 30% |
| Commercial & International | 13% |
| Defense Systems | 13% |
Workforce: 47,000 globally (41,900 US); ~25,000 hold US security clearances (multi-billion replacement cost moat).
Risk factor inventory (10-K Item 1A, filed Feb 17, 2026): Top 7: (1) US Govt budget dependence 87%, (2) FFP contract exposure, (3) Cybersecurity, (4) Regulatory/CMMC compliance, (5) Security clearance dependency 53%, (6) Capital structure D/E 107.7, (7) Talent retention.
| Metric | Value | Note |
| Revenue (TTM) | $17.17B | +3% YoY (FY 2025) |
| Net Income (TTM) | $1.45B | Strong YoY |
| EBITDA Margin (FY 2025) | 14.1% | Mid-13% guided FY 2026 (-80bps) |
| Operating Margin (FY 2025) | 11.2% | Improving |
| ROE | 31.0% | Buyback-amplified |
| Forward P/E | 11.3x | Cheap vs sector peers (BAH 19x, SAIC 14x) |
| PEG | 2.46 | High due to slowing growth |
| Backlog (FY 2025) | $49.0B | 2.85x revenue coverage |
| Funded backlog | $9.7B | +15% YoY |
| FY 2025 book-to-bill | 1.0x | Below peer 1.05-1.10x |
| Q4 2025 book-to-bill | 1.3x | Re-acceleration |
| FY 2026 guide | $17.5-$17.9B | +1.7% to +4% growth |
| US Gov % of revenue | 87% | High concentration |
| Net debt | ~$3.9B | D/E 107.7 (highest among peers) |